Greatbatch Inc  

(Public, NYSE:GB)   Watch this stock  
Find more results for greatbatch
46.90
-0.78 (-1.64%)
Apr 23 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 46.89 - 47.87
52 week 27.03 - 47.96
Open 47.51
Vol / Avg. 130,391.00/139,255.00
Mkt cap 1.16B
P/E 32.75
Div/yield     -
EPS 1.43
Shares 24.82M
Beta 0.96
Inst. own 92%
Jul 21, 2014
Q2 2014 Greatbatch, Inc. Earnings Release (Estimated) Add to calendar
May 16, 2014
Greatbatch, Inc. Annual Shareholder Meeting - 10:00AM EDT - Add to calendar
Apr 30, 2014
Q1 2014 Greatbatch, Inc. Earnings Conference Call - 5:00PM EDT - Add to calendar
Apr 30, 2014
Q1 2014 Greatbatch, Inc. Earnings Release - 4:00PM EDT - Add to calendar
Feb 25, 2014
Q4 2013 Greatbatch, Inc. Earnings Conference Call - Webcast
Feb 24, 2014
Q4 2013 Greatbatch, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Jan '14) 2014
Net profit margin 5.54% 5.46%
Operating margin 7.28% 9.24%
EBITD margin - 17.03%
Return on average assets 4.10% 4.07%
Return on average equity 6.83% 7.09%
Employees 3,385 -
CDP Score - -

Address

SUITE 101, 2591 DALLAS PARKWAY
FRISCO, TX 75034
United States - Map
+1-716-7595600 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Greatbatch, Inc. (Greatbatch) is developer and manufacturer of components for implantable medical devices (IMDs) and Electrochem batteries. The Company operates in two segments: Greatbatch Medical and Electrochem Solutions (Electrochem). The Company�s customers include large multi-national original equipment manufacturers (OEMs). The Greatbatch Medical segment designs and manufactures medical devices and components primarily for the cardiac rhythm management (CRM), neuromodulation, vascular access and orthopaedic markets. In addition, Greatbatch Medical offers assembly and design engineering services for products that incorporate Greatbatch Medical components. Electrochem segment provides technology solutions. On February 16, 2012, Greatbatch purchased NeuroNexus Technologies, Inc. (NeuroNexus). On December 15, 2011, Electrochem acquired Micro Power Electronics, Inc. (Micro Power).

Officers and directors

Bill R. Sanford Independent Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
Thomas J. Hook President, Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael Dinkins Chief Financial Officer, Senior Vice President
Age: 58
Bio & Compensation  - Reuters
Andrew P. Holman Executive Vice President - Global Sales & Marketing
Bio & Compensation  - Reuters
Mauricio Arellano Executive Vice President - Global Operations
Age: 46
Bio & Compensation  - Reuters
Susan M. Bratton Executive Vice President - Business Development
Age: 56
Bio & Compensation  - Reuters
George Cintra Senior Vice President, Chief Technology Officer
Bio & Compensation  - Reuters
Timothy G. McEvoy Senior Vice President, General Counsel, Secretary
Age: 55
Bio & Compensation  - Reuters
Michelle Graham Senior Vice President - Human Resources
Age: 46
Bio & Compensation  - Reuters
Daniel R. Kaiser Ph.D. Vice President, Chief Technology Officer
Age: 43
Bio & Compensation  - Reuters